25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

524816 (NATCO Pharma Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze NATCO Pharma Limited together

I guess you are interested in NATCO Pharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – NATCO Pharma Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – NATCO Pharma Limited’s Price Targets

I'm going to help you getting a better view of NATCO Pharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about NATCO Pharma Limited

I send you an email if I find something interesting about NATCO Pharma Limited.

1. Quick Overview

1.1. Quick analysis of NATCO Pharma Limited (30 sec.)










1.2. What can you expect buying and holding a share of NATCO Pharma Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.28
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR425.01
Expected worth in 1 year
INR817.88
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR416.95
Return On Investment
42.8%

For what price can you sell your share?

Current Price per Share
INR973.55
Expected price per share
INR858.10 - INR1,146
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of NATCO Pharma Limited (5 min.)




Live pricePrice per Share (EOD)
INR973.55
Intrinsic Value Per Share
INR672.50 - INR1,573.52
Total Value Per Share
INR1,097.50 - INR1,998.52

2.2. Growth of NATCO Pharma Limited (5 min.)




Is NATCO Pharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$890.6m$684.8m$205.8m23.1%

How much money is NATCO Pharma Limited making?

Current yearPrevious yearGrowGrow %
Making money$220.5m$162.4m$58.1m26.4%
Net Profit Margin42.6%34.7%--

How much money comes from the company's main activities?

2.3. Financial Health of NATCO Pharma Limited (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of NATCO Pharma Limited?

Welcome investor! NATCO Pharma Limited's management wants to use your money to grow the business. In return you get a share of NATCO Pharma Limited.

First you should know what it really means to hold a share of NATCO Pharma Limited. And how you can make/lose money.

Speculation

The Price per Share of NATCO Pharma Limited is INR973.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of NATCO Pharma Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in NATCO Pharma Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR425.01. Based on the TTM, the Book Value Change Per Share is INR98.22 per quarter. Based on the YOY, the Book Value Change Per Share is INR59.69 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR6.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of NATCO Pharma Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps1.230.1%1.230.1%0.910.1%0.870.1%0.600.1%0.450.0%
Usd Book Value Change Per Share1.150.1%1.150.1%0.700.1%0.750.1%0.510.1%0.550.1%
Usd Dividend Per Share0.070.0%0.070.0%0.110.0%0.080.0%0.070.0%0.080.0%
Usd Total Gains Per Share1.220.1%1.220.1%0.810.1%0.830.1%0.580.1%0.640.1%
Usd Price Per Share16.23-16.23-9.49-10.76-10.82-8.71-
Price to Earnings Ratio13.18-13.18-10.47-12.66-34.96-26.38-
Price-to-Total Gains Ratio13.31-13.31-11.72-13.14-30.56-24.06-
Price to Book Ratio3.26-3.26-2.48-2.62-3.19-3.43-
Price-to-Total Gains Ratio13.31-13.31-11.72-13.14-30.56-24.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.390535
Number of shares87
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.07
Usd Book Value Change Per Share1.150.51
Usd Total Gains Per Share1.220.58
Gains per Quarter (87 shares)106.1050.80
Gains per Year (87 shares)424.41203.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12540041426177193
24980083852355396
3741200126278532599
49816001686104709802
5123200021101308871005
61472399253415510641208
71722799295818112411411
81963199338220714191614
92213599380623315961817
102453999423025917732020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of NATCO Pharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--98.21998.2190%59.687+65%63.804+54%43.550+126%47.223+108%
Book Value Per Share--425.007425.0070%326.788+30%339.632+25%295.707+44%213.785+99%
Current Ratio--5.5865.5860%4.136+35%4.705+19%4.415+27%3.572+56%
Debt To Asset Ratio--0.1180.1180%0.152-23%0.136-13%0.143-17%0.183-36%
Debt To Equity Ratio--0.1340.1340%0.180-26%0.158-15%0.167-20%0.231-42%
Dividend Per Share--6.0196.0190%9.536-37%7.019-14%6.361-5%7.135-16%
Enterprise Value--238294122651.000238294122651.0000%134761926544.000+77%158532966023.000+50%161824554706.900+47%144327007351.828+65%
Eps--105.265105.2650%77.511+36%73.992+42%51.094+106%38.166+176%
Ev To Sales Ratio--5.3805.3800%3.370+60%4.179+29%5.844-8%5.858-8%
Free Cash Flow Per Share--66.17266.1720%47.619+39%49.686+33%28.146+135%17.915+269%
Free Cash Flow To Equity Per Share--66.17266.1720%47.619+39%43.054+54%22.512+194%16.561+300%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1573.517----------
Intrinsic Value_10Y_min--672.498----------
Intrinsic Value_1Y_max--73.132----------
Intrinsic Value_1Y_min--38.430----------
Intrinsic Value_3Y_max--284.165----------
Intrinsic Value_3Y_min--141.233----------
Intrinsic Value_5Y_max--572.882----------
Intrinsic Value_5Y_min--271.486----------
Market Cap--248479122651.000248479122651.0000%145293926544.000+71%165406966023.000+50%167320154706.900+49%134746406616.645+84%
Net Profit Margin--0.4260.4260%0.347+23%0.346+23%0.268+59%0.258+65%
Operating Margin----0%-0%-0%-0%0.157-100%
Operating Ratio--0.7130.7130%0.788-10%0.821-13%0.941-24%0.858-17%
Pb Ratio2.291-42%3.2643.2640%2.482+31%2.616+25%3.195+2%3.431-5%
Pe Ratio9.249-42%13.17913.1790%10.466+26%12.656+4%34.961-62%26.383-50%
Price Per Share973.550-42%1387.3001387.3000%811.200+71%919.983+51%925.160+50%744.110+86%
Price To Free Cash Flow Ratio14.712-42%20.96520.9650%17.035+23%17.974+17%73.323-71%121.369-83%
Price To Total Gains Ratio9.340-42%13.30913.3090%11.719+14%13.140+1%30.564-56%24.058-45%
Quick Ratio--4.2864.2860%2.978+44%3.563+20%3.001+43%2.107+103%
Return On Assets--0.2180.2180%0.201+9%0.182+20%0.134+63%0.140+56%
Return On Equity--0.2480.2480%0.237+4%0.211+18%0.156+59%0.173+43%
Total Gains Per Share--104.238104.2380%69.223+51%70.823+47%49.911+109%54.358+92%
Usd Book Value--890639100.000890639100.0000%684812700.000+30%715228800.000+25%625350960.000+42%468047970.000+90%
Usd Book Value Change Per Share--1.1491.1490%0.698+65%0.747+54%0.510+126%0.553+108%
Usd Book Value Per Share--4.9734.9730%3.823+30%3.974+25%3.460+44%2.501+99%
Usd Dividend Per Share--0.0700.0700%0.112-37%0.082-14%0.074-5%0.083-16%
Usd Enterprise Value--2788041235.0172788041235.0170%1576714540.565+77%1854835702.469+50%1893347290.071+47%1688625986.016+65%
Usd Eps--1.2321.2320%0.907+36%0.866+42%0.598+106%0.447+176%
Usd Free Cash Flow--138668400.000138668400.0000%99789300.000+39%104582400.000+33%59192640.000+134%33416370.000+315%
Usd Free Cash Flow Per Share--0.7740.7740%0.557+39%0.581+33%0.329+135%0.210+269%
Usd Free Cash Flow To Equity Per Share--0.7740.7740%0.557+39%0.504+54%0.263+194%0.194+300%
Usd Market Cap--2907205735.0172907205735.0170%1699938940.565+71%1935261502.469+50%1957645810.071+49%1576532957.415+84%
Usd Price Per Share11.391-42%16.23116.2310%9.491+71%10.764+51%10.824+50%8.706+86%
Usd Profit--220591800.000220591800.0000%162431100.000+36%155571000.000+42%107637660.000+105%82419480.000+168%
Usd Revenue--518251500.000518251500.0000%467859600.000+11%434280600.000+19%354095820.000+46%286520130.000+81%
Usd Total Gains Per Share--1.2201.2200%0.810+51%0.829+47%0.584+109%0.636+92%
 EOD+4 -2MRQTTM+0 -0YOY+31 -63Y+31 -65Y+31 -610Y+32 -6

3.3 Fundamental Score

Let's check the fundamental score of NATCO Pharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.249
Price to Book Ratio (EOD)Between0-12.291
Net Profit Margin (MRQ)Greater than00.426
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.286
Current Ratio (MRQ)Greater than15.586
Debt to Asset Ratio (MRQ)Less than10.118
Debt to Equity Ratio (MRQ)Less than10.134
Return on Equity (MRQ)Greater than0.150.248
Return on Assets (MRQ)Greater than0.050.218
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of NATCO Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.195
Ma 20Greater thanMa 50895.583
Ma 50Greater thanMa 100872.651
Ma 100Greater thanMa 200846.429
OpenGreater thanClose926.700
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About NATCO Pharma Limited

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ NATCO Pharma Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • A Net Profit Margin of 42.6%Β means thatΒ ₹0.43 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NATCO Pharma Limited:

  • The MRQ is 42.6%. The company is making a huge profit. +2
  • The TTM is 42.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ42.6%TTM42.6%0.0%
TTM42.6%YOY34.7%+7.8%
TTM42.6%5Y26.8%+15.8%
5Y26.8%10Y25.8%+0.9%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ42.6%11.4%+31.2%
TTM42.6%10.2%+32.4%
YOY34.7%10.5%+24.2%
3Y34.6%9.4%+25.2%
5Y26.8%12.7%+14.1%
10Y25.8%11.6%+14.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ NATCO Pharma Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • 21.8% Return on Assets means thatΒ NATCO Pharma Limited generatedΒ ₹0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NATCO Pharma Limited:

  • The MRQ is 21.8%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 21.8%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ21.8%TTM21.8%0.0%
TTM21.8%YOY20.1%+1.7%
TTM21.8%5Y13.4%+8.4%
5Y13.4%10Y14.0%-0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ21.8%4.9%+16.9%
TTM21.8%4.9%+16.9%
YOY20.1%4.4%+15.7%
3Y18.2%5.2%+13.0%
5Y13.4%4.5%+8.9%
10Y14.0%4.6%+9.4%
4.3.1.3. Return on Equity

Shows how efficient NATCO Pharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • 24.8% Return on Equity means NATCO Pharma Limited generated ₹0.25Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NATCO Pharma Limited:

  • The MRQ is 24.8%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 24.8%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ24.8%TTM24.8%0.0%
TTM24.8%YOY23.7%+1.1%
TTM24.8%5Y15.6%+9.2%
5Y15.6%10Y17.3%-1.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ24.8%9.6%+15.2%
TTM24.8%9.6%+15.2%
YOY23.7%7.0%+16.7%
3Y21.1%7.6%+13.5%
5Y15.6%7.6%+8.0%
10Y17.3%8.7%+8.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of NATCO Pharma Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient NATCO Pharma Limited is operatingΒ .

  • Measures how much profit NATCO Pharma Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NATCO Pharma Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y15.7%-15.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
TTM-9.6%-9.6%
YOY-8.1%-8.1%
3Y-4.2%-4.2%
5Y-9.0%-9.0%
10Y15.7%10.4%+5.3%
4.3.2.2. Operating Ratio

Measures how efficient NATCO Pharma Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Pharmaceuticals industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are ₹0.71 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of NATCO Pharma Limited:

  • The MRQ is 0.713. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.713. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.713TTM0.7130.000
TTM0.713YOY0.788-0.075
TTM0.7135Y0.941-0.228
5Y0.94110Y0.858+0.083
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7131.231-0.518
TTM0.7131.176-0.463
YOY0.7881.220-0.432
3Y0.8211.233-0.412
5Y0.9411.226-0.285
10Y0.8581.211-0.353
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of NATCO Pharma Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if NATCO Pharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Pharmaceuticals industry mean).
  • A Current Ratio of 5.59Β means the company has ₹5.59 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of NATCO Pharma Limited:

  • The MRQ is 5.586. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.586. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.586TTM5.5860.000
TTM5.586YOY4.136+1.450
TTM5.5865Y4.415+1.170
5Y4.41510Y3.572+0.843
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5861.933+3.653
TTM5.5861.986+3.600
YOY4.1362.234+1.902
3Y4.7052.088+2.617
5Y4.4152.256+2.159
10Y3.5722.036+1.536
4.4.3.2. Quick Ratio

Measures if NATCO Pharma Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • A Quick Ratio of 4.29Β means the company can pay off ₹4.29 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NATCO Pharma Limited:

  • The MRQ is 4.286. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.286. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.286TTM4.2860.000
TTM4.286YOY2.978+1.308
TTM4.2865Y3.001+1.286
5Y3.00110Y2.107+0.894
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2861.059+3.227
TTM4.2861.109+3.177
YOY2.9781.245+1.733
3Y3.5631.424+2.139
5Y3.0011.642+1.359
10Y2.1071.573+0.534
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of NATCO Pharma Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of NATCO Pharma LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ NATCO Pharma Limited to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.12Β means that NATCO Pharma Limited assets areΒ financed with 11.8% credit (debt) and the remaining percentage (100% - 11.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of NATCO Pharma Limited:

  • The MRQ is 0.118. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.118. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.118TTM0.1180.000
TTM0.118YOY0.152-0.034
TTM0.1185Y0.143-0.025
5Y0.14310Y0.183-0.040
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1180.324-0.206
TTM0.1180.326-0.208
YOY0.1520.336-0.184
3Y0.1360.314-0.178
5Y0.1430.328-0.185
10Y0.1830.338-0.155
4.5.4.2. Debt to Equity Ratio

Measures ifΒ NATCO Pharma Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 13.4% means that company has ₹0.13 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NATCO Pharma Limited:

  • The MRQ is 0.134. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.134. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.134TTM0.1340.000
TTM0.134YOY0.180-0.046
TTM0.1345Y0.167-0.033
5Y0.16710Y0.231-0.063
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1340.492-0.358
TTM0.1340.492-0.358
YOY0.1800.547-0.367
3Y0.1580.488-0.330
5Y0.1670.502-0.335
10Y0.2310.528-0.297
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings NATCO Pharma Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ NATCO Pharma Limited to theΒ Pharmaceuticals industry mean.
  • A PE ratio of 13.18 means the investor is paying ₹13.18Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NATCO Pharma Limited:

  • The EOD is 9.249. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.179. Based on the earnings, the company is underpriced. +1
  • The TTM is 13.179. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.249MRQ13.179-3.931
MRQ13.179TTM13.1790.000
TTM13.179YOY10.466+2.714
TTM13.1795Y34.961-21.781
5Y34.96110Y26.383+8.578
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD9.24928.505-19.256
MRQ13.17925.404-12.225
TTM13.17927.574-14.395
YOY10.46622.687-12.221
3Y12.65623.741-11.085
5Y34.96128.695+6.266
10Y26.38328.267-1.884
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NATCO Pharma Limited:

  • The EOD is 14.712. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 20.965. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.965. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.712MRQ20.965-6.253
MRQ20.965TTM20.9650.000
TTM20.965YOY17.035+3.930
TTM20.9655Y73.323-52.358
5Y73.32310Y121.369-48.046
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD14.71225.213-10.501
MRQ20.96522.139-1.174
TTM20.96517.570+3.395
YOY17.03527.354-10.319
3Y17.97436.662-18.688
5Y73.32336.120+37.203
10Y121.36930.424+90.945
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ NATCO Pharma Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 3.26 means the investor is paying ₹3.26Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of NATCO Pharma Limited:

  • The EOD is 2.291. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.264. Based on the equity, the company is fair priced.
  • The TTM is 3.264. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.291MRQ3.264-0.974
MRQ3.264TTM3.2640.000
TTM3.264YOY2.482+0.782
TTM3.2645Y3.195+0.069
5Y3.19510Y3.431-0.236
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD2.2913.941-1.650
MRQ3.2644.187-0.923
TTM3.2644.216-0.952
YOY2.4823.209-0.727
3Y2.6163.242-0.626
5Y3.1953.625-0.430
10Y3.4313.591-0.160
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets86,308,000
Total Liabilities10,185,000
Total Stockholder Equity76,070,000
 As reported
Total Liabilities 10,185,000
Total Stockholder Equity+ 76,070,000
Total Assets = 86,308,000

Assets

Total Assets86,308,000
Total Current Assets52,700,000
Long-term Assets33,608,000
Total Current Assets
Cash And Cash Equivalents 1,200,000
Short-term Investments 27,973,000
Net Receivables 12,466,000
Inventory 7,658,000
Other Current Assets 3,309,000
Total Current Assets  (as reported)52,700,000
Total Current Assets  (calculated)52,606,000
+/- 94,000
Long-term Assets
Property Plant Equipment 26,573,000
Goodwill 574,000
Intangible Assets 2,087,000
Long-term Assets Other 490,000
Long-term Assets  (as reported)33,608,000
Long-term Assets  (calculated)29,724,000
+/- 3,884,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,435,000
Long-term Liabilities750,000
Total Stockholder Equity76,070,000
Total Current Liabilities
Short Long Term Debt 2,731,000
Accounts payable 2,749,000
Other Current Liabilities 1,223,000
Total Current Liabilities  (as reported)9,435,000
Total Current Liabilities  (calculated)6,703,000
+/- 2,732,000
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt63,000
Long-term Liabilities  (as reported)750,000
Long-term Liabilities  (calculated)63,000
+/- 687,000
Total Stockholder Equity
Total Stockholder Equity (as reported)76,070,000
Total Stockholder Equity (calculated)0
+/- 76,070,000
Other
Capital Stock358,000
Common Stock Shares Outstanding 179,110
Net Debt 1,531,000
Net Invested Capital 78,801,000
Net Working Capital 43,265,000
Property Plant and Equipment Gross 26,573,000



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
18,217,000
23,176,000
37,151,000
43,031,000
45,878,000
47,919,000
51,091,000
56,574,000
69,063,000
86,308,000
86,308,00069,063,00056,574,00051,091,00047,919,00045,878,00043,031,00037,151,00023,176,00018,217,000
   > Total Current Assets 
8,370,000
10,873,000
21,307,000
23,472,000
23,256,000
23,373,000
24,972,000
30,003,000
40,235,000
52,700,000
52,700,00040,235,00030,003,00024,972,00023,373,00023,256,00023,472,00021,307,00010,873,0008,370,000
       Cash And Cash Equivalents 
0
358,000
1,837,000
283,000
198,000
258,000
1,111,000
1,319,000
704,000
1,200,000
1,200,000704,0001,319,0001,111,000258,000198,000283,0001,837,000358,0000
       Short-term Investments 
0
321,000
684,000
3,977,000
715,000
3,983,000
2,950,000
6,612,000
17,077,000
27,973,000
27,973,00017,077,0006,612,0002,950,0003,983,000715,0003,977,000684,000321,0000
       Net Receivables 
2,616,000
4,752,000
6,375,000
5,062,000
5,513,000
4,491,000
6,458,000
8,846,000
11,889,000
12,466,000
12,466,00011,889,0008,846,0006,458,0004,491,0005,513,0005,062,0006,375,0004,752,0002,616,000
       Inventory 
3,573,000
3,489,000
4,384,000
5,908,000
6,987,000
9,104,000
8,620,000
8,089,000
7,005,000
7,658,000
7,658,0007,005,0008,089,0008,620,0009,104,0006,987,0005,908,0004,384,0003,489,0003,573,000
       Other Current Assets 
1,192,000
1,660,000
7,449,000
7,088,000
8,147,000
3,899,000
3,586,000
4,686,000
2,759,000
3,309,000
3,309,0002,759,0004,686,0003,586,0003,899,0008,147,0007,088,0007,449,0001,660,0001,192,000
   > Long-term Assets 
0
12,303,000
15,844,000
19,559,000
22,622,000
24,546,000
26,119,000
26,571,000
28,828,000
33,608,000
33,608,00028,828,00026,571,00026,119,00024,546,00022,622,00019,559,00015,844,00012,303,0000
       Property Plant Equipment 
9,164,000
11,635,000
14,927,000
18,561,000
20,937,000
22,372,000
23,084,000
23,034,000
24,350,000
26,573,000
26,573,00024,350,00023,034,00023,084,00022,372,00020,937,00018,561,00014,927,00011,635,0009,164,000
       Goodwill 
0
0
0
0
0
0
507,000
552,000
560,000
574,000
574,000560,000552,000507,000000000
       Intangible Assets 
55,000
58,000
59,000
87,000
88,000
94,000
822,000
1,326,000
1,371,000
2,087,000
2,087,0001,371,0001,326,000822,00094,00088,00087,00059,00058,00055,000
       Long-term Assets Other 
0
125,000
-59,000
17,000
-1,000
285,000
469,000
271,000
694,000
490,000
490,000694,000271,000469,000285,000-1,00017,000-59,000125,0000
> Total Liabilities 
5,260,000
6,683,000
6,429,000
8,141,000
8,143,000
6,703,000
8,455,000
7,836,000
10,532,000
10,185,000
10,185,00010,532,0007,836,0008,455,0006,703,0008,143,0008,141,0006,429,0006,683,0005,260,000
   > Total Current Liabilities 
4,931,000
6,265,000
5,920,000
7,287,000
6,853,000
5,256,000
7,104,000
6,831,000
9,728,000
9,435,000
9,435,0009,728,0006,831,0007,104,0005,256,0006,853,0007,287,0005,920,0006,265,0004,931,000
       Short-term Debt 
984,000
2,216,000
1,732,000
3,863,000
3,277,000
0
0
1,650,000
0
0
001,650,000003,277,0003,863,0001,732,0002,216,000984,000
       Short Long Term Debt 
0
2,216,000
1,732,000
3,863,000
3,277,000
2,821,000
4,205,000
1,650,000
3,781,000
2,731,000
2,731,0003,781,0001,650,0004,205,0002,821,0003,277,0003,863,0001,732,0002,216,0000
       Accounts payable 
0
20,000
48,000
2,170,000
2,554,000
1,462,000
1,618,000
2,638,000
2,355,000
2,749,000
2,749,0002,355,0002,638,0001,618,0001,462,0002,554,0002,170,00048,00020,0000
       Other Current Liabilities 
0
113,000
126,000
127,000
130,000
122,000
369,000
1,408,000
488,000
1,223,000
1,223,000488,0001,408,000369,000122,000130,000127,000126,000113,0000
   > Long-term Liabilities 
0
377,000
471,000
834,000
1,178,000
1,429,000
1,351,000
-41,631,000
804,000
750,000
750,000804,000-41,631,0001,351,0001,429,0001,178,000834,000471,000377,0000
       Long term Debt Total 
0
0
0
0
9,000
9,000
80,000
11,000
0
0
0011,00080,0009,0009,0000000
> Total Stockholder Equity
12,957,000
16,493,000
30,722,000
34,890,000
37,735,000
41,216,000
42,636,000
48,738,000
58,531,000
76,070,000
76,070,00058,531,00048,738,00042,636,00041,216,00037,735,00034,890,00030,722,00016,493,00012,957,000
   Common Stock
348,000
349,000
369,000
365,000
364,000
365,000
365,000
365,000
0
0
00365,000365,000365,000364,000365,000369,000349,000348,000
   Retained Earnings 
6,554,000
10,055,000
15,288,000
20,601,000
23,748,000
26,979,000
27,822,000
34,045,000
44,657,000
0
044,657,00034,045,00027,822,00026,979,00023,748,00020,601,00015,288,00010,055,0006,554,000
   Capital Surplus 
6,112,000
6,178,000
15,206,000
14,048,000
13,729,000
13,915,000
14,078,000
14,065,000
0
0
0014,065,00014,078,00013,915,00013,729,00014,048,00015,206,0006,178,0006,112,000
   Treasury Stock0000000000
   Other Stockholders Equity 
-57,000
-89,000
-141,000
-124,000
-106,000
-43,000
371,000
263,000
0
0
00263,000371,000-43,000-106,000-124,000-141,000-89,000-57,000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue44,295,000
Cost of Revenue-6,898,000
Gross Profit37,397,00037,397,000
 
Operating Income (+$)
Gross Profit37,397,000
Operating Expense-24,687,000
Operating Income19,608,00012,710,000
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense24,687,0000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-239,000
Other Finance Cost-0
Net Interest Income-239,000
 
Pretax Income (+$)
Operating Income19,608,000
Net Interest Income-239,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)22,914,00019,608,000
EBIT - interestExpense = -239,000
18,854,000
19,093,000
Interest Expense239,000
Earnings Before Interest and Taxes (EBIT)023,153,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax22,914,000
Tax Provision-4,080,000
Net Income From Continuing Ops18,834,00018,834,000
Net Income18,854,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0239,000
 

Technical Analysis of NATCO Pharma Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of NATCO Pharma Limited. The general trend of NATCO Pharma Limited is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine NATCO Pharma Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. NATCO Pharma Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NATCO Pharma Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 965.96 < 967.05 < 1,146.

The bearish price targets are: 970.00 > 955.00 > 858.10.

Know someone who trades $524816? Share this with them.πŸ‘‡

NATCO Pharma Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NATCO Pharma Limited. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NATCO Pharma Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NATCO Pharma Limited. The current macd is 17.14.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the NATCO Pharma Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for NATCO Pharma Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the NATCO Pharma Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
NATCO Pharma Limited Daily Moving Average Convergence/Divergence (MACD) ChartNATCO Pharma Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NATCO Pharma Limited. The current adx is 23.36.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy NATCO Pharma Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
NATCO Pharma Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NATCO Pharma Limited. The current sar is 865.98.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
NATCO Pharma Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NATCO Pharma Limited. The current rsi is 70.19. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
NATCO Pharma Limited Daily Relative Strength Index (RSI) ChartNATCO Pharma Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NATCO Pharma Limited. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the NATCO Pharma Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
NATCO Pharma Limited Daily Stochastic Oscillator ChartNATCO Pharma Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NATCO Pharma Limited. The current cci is 170.53.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
NATCO Pharma Limited Daily Commodity Channel Index (CCI) ChartNATCO Pharma Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NATCO Pharma Limited. The current cmo is 51.85.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
NATCO Pharma Limited Daily Chande Momentum Oscillator (CMO) ChartNATCO Pharma Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NATCO Pharma Limited. The current willr is -2.69700801.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
NATCO Pharma Limited Daily Williams %R ChartNATCO Pharma Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of NATCO Pharma Limited.

NATCO Pharma Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NATCO Pharma Limited. The current atr is 29.58.

NATCO Pharma Limited Daily Average True Range (ATR) ChartNATCO Pharma Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NATCO Pharma Limited. The current obv is 2,642,588.

NATCO Pharma Limited Daily On-Balance Volume (OBV) ChartNATCO Pharma Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NATCO Pharma Limited. The current mfi is 67.13.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
NATCO Pharma Limited Daily Money Flow Index (MFI) ChartNATCO Pharma Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NATCO Pharma Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

NATCO Pharma Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NATCO Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.195
Ma 20Greater thanMa 50895.583
Ma 50Greater thanMa 100872.651
Ma 100Greater thanMa 200846.429
OpenGreater thanClose926.700
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of NATCO Pharma Limited with someone you think should read this too:
  • Are you bullish or bearish on NATCO Pharma Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about NATCO Pharma Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NATCO Pharma Limited

I send you an email if I find something interesting about NATCO Pharma Limited.


Comments

How you think about this?

Leave a comment

Stay informed about NATCO Pharma Limited.

Receive notifications about NATCO Pharma Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.